Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Increasing Road Accidents And Surgical Procedures
3.2.2. Escalating Palliative Care For Patients Suffering Intensely
3.2.3. Usage Of Abuse Deterrent Formulations To Restrict The Opioid Abuse
3.2.4. Growing Occurrence Of Chronic Pain
3.3. Key Restraints
3.3.1. Misuse Of Opioids
3.3.2. Stringent Regulatory Framework

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework
4.6. Technological Advancement

5. Market By Product
5.1. Buprenorphine
5.2. Fentanyl
5.3. Hydrocodone
5.4. Morphine
5.5. Oxycodone
5.6. Tramadol
5.7. Other Products

6. Market By Application
6.1. Pain Relief
6.1.1. Cancer Pain
6.1.2. Postoperative Pain Management
6.1.3. Low Back Pain
6.1.4. Orthopedic
6.1.5. Fibromyalgia
6.1.6. Neuropathic
6.2. Anesthesia
6.3. Cough Suppression
6.4. Diarrhea Suppression
6.5. Deaddiction

7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. Germany
7.1.3. France
7.1.4. Italy
7.1.5. Russia
7.1.6. Belgium
7.1.7. Poland
7.1.8. Rest Of Europe

8. Company Profiles
8.1. Acura Pharmaceuticals Inc
8.2. Allergan Plc
8.3. Biodelivery Sciences International Inc
8.4. Cipher Pharmaceuticals Inc
8.5. Collegium Pharmaceutical Inc
8.6. Daiichi Sankyo Inc
8.7. Egalet Corp
8.8. Hikma Pharmaceuticals Plc
8.9. Indivior Inc
8.10. Janssen Pharmaceuticals Inc
8.11. Johnson & Johnson
8.12. Lannett Co. Inc
8.13. Lupin Ltd
8.14. Mylan Nv
8.15. Pfizer Inc
8.16. Purdue Pharma Lp
8.17. Sanofi-Aventis S.A
8.18. Sun Pharmaceutical Industries Limited (Sun Pharma)
8.19. Teva Pharmaceutical Industries Ltd



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Opioids Drugs Market, Growth Potential, By Product, In 2019
Figure 6: Europe Opioids Drugs Market, By Buprenorphine, 2019-2028 (In $ Million)
Figure 7: Europe Opioids Drugs Market, By Fentanyl, 2019-2028 (In $ Million)
Figure 8: Europe Opioids Drugs Market, By Hydrocodone, 2019-2028 (In $ Million)
Figure 9: Europe Opioids Drugs Market, By Morphine, 2019-2028 (In $ Million)
Figure 10: Europe Opioids Drugs Market, By Oxycodone, 2019-2028 (In $ Million)
Figure 11: Europe Opioids Drugs Market, By Tramadol, 2019-2028 (In $ Million)
Figure 12: Europe Opioids Drugs Market, By Other Products, 2019-2028 (In $ Million)
Figure 13: Europe Opioids Drugs Market, Growth Potential, By Application, In 2019
Figure 14: Europe Opioids Drugs Market, By Pain Relief, 2019-2028 (In $ Million)
Figure 15: Europe Pain Relief Market, By Cancer Pain, 2019-2028 (In $ Million)
Figure 16: Europe Pain Relief Market, By Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 17: Europe Pain Relief Market, By Low Back Pain, 2019-2028 (In $ Million)
Figure 18: Europe Pain Relief Market, By Orthopedic, 2019-2028 (In $ Million)
Figure 19: Europe Pain Relief Market, By Fibromyalgia, 2019-2028 (In $ Million)
Figure 20: Europe Pain Relief Market, By Neuropathic, 2019-2028 (In $ Million)
Figure 21: Europe Opioids Drugs Market, By Anesthesia, 2019-2028 (In $ Million)
Figure 22: Europe Opioids Drugs Market, By Cough Suppression, 2019-2028 (In $ Million)
Figure 23: Europe Opioids Drugs Market, By Diarrhea Suppression, 2019-2028 (In $ Million)
Figure 24: Europe Opioids Drugs Market, By Deaddiction, 2019-2028 (In $ Million)
Figure 25: Europe Opioids Drugs Market, Country Outlook, 2018 & 2028 (In %)
Figure 26: The United Kingdom Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 27: Germany Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 28: France Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 29: Italy Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 30: Russia Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 31: Belgium Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 32: Poland Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 33: Rest Of Europe Opioids Drugs Market, 2019-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
TABLE 2: EUROPE OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: EUROPE OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: EUROPE OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: EUROPE OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: EUROPE PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):
TABLE 7: EUROPE PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION):
TABLE 8: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)